Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012471454> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2012471454 endingPage "16" @default.
- W2012471454 startingPage "9" @default.
- W2012471454 abstract "Abstract Background The majority of childhood acute myeloid leukemia (AML) patients lack a matched‐related bone marrow transplant (BMT) donor in first remission. Procedure Disease‐free survival (DFS), overall survival (OS), relapse‐free survival (RFS), and post‐relapse outcome were evaluated for children with de novo AML on CCG 213 and the standard timing (ST) and intensive timing (IT) induction arms of CCG 2891 who were randomized to (intent‐to‐treat, ITT) or who received (as‐treated, AT) only chemotherapy intensification. Results Outcomes at 8 years post‐induction in ITT analysis of chemotherapy intensification were as follows: 31% DFS, 43% OS on CCG 213; 34% DFS, 51% OS on CCG 2891 ST; 48% DFS, 56% OS on CCG 2891 IT. All toxic deaths during and following Capizzi II chemotherapy intensification on both protocols were in patients >3 years of age ( P ≤ 0.001). Black race was a significant poor prognostic factor for OS ( P = 0.008, hazard ratio: 1.74, 95% CI: 1.15–2.61). Overall 48% of patients on both trials relapsed and 19.1% of patients who relapsed on these trials survived. CR1 >12 months portends a much better OS for patients who relapse. Post‐relapse treatment included BMT in 47% of patients. Conclusions OS on CCG 2891 was superior to CCG 213 but equivalent between ST and IT arms due to better salvage rates post‐relapse in ST patients. Overall survival for childhood AML in the absence of BMT in CR1 is influenced by duration of CR1 and by race. Pediatr Blood Cancer 2008;50:9–16. © 2007 Wiley‐Liss, Inc." @default.
- W2012471454 created "2016-06-24" @default.
- W2012471454 creator A5007262193 @default.
- W2012471454 creator A5018786888 @default.
- W2012471454 creator A5025381113 @default.
- W2012471454 creator A5036356438 @default.
- W2012471454 creator A5060210860 @default.
- W2012471454 creator A5066861312 @default.
- W2012471454 date "2007-11-19" @default.
- W2012471454 modified "2023-10-11" @default.
- W2012471454 title "Outcomes in childhood AML in the absence of transplantation in first remission—Children's Cancer Group (CCG) studies 2891 and CCG 213" @default.
- W2012471454 cites W1847612791 @default.
- W2012471454 cites W1860795225 @default.
- W2012471454 cites W1937764639 @default.
- W2012471454 cites W1964952394 @default.
- W2012471454 cites W1973617793 @default.
- W2012471454 cites W1973655959 @default.
- W2012471454 cites W1994351520 @default.
- W2012471454 cites W2015129144 @default.
- W2012471454 cites W2018895375 @default.
- W2012471454 cites W2020904615 @default.
- W2012471454 cites W2044031908 @default.
- W2012471454 cites W2058120958 @default.
- W2012471454 cites W2090340916 @default.
- W2012471454 cites W2093979623 @default.
- W2012471454 cites W2110496778 @default.
- W2012471454 cites W2133262115 @default.
- W2012471454 cites W2157633619 @default.
- W2012471454 cites W2159289068 @default.
- W2012471454 cites W2167401533 @default.
- W2012471454 cites W2175893112 @default.
- W2012471454 cites W2409426682 @default.
- W2012471454 cites W4474461 @default.
- W2012471454 doi "https://doi.org/10.1002/pbc.21123" @default.
- W2012471454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17252564" @default.
- W2012471454 hasPublicationYear "2007" @default.
- W2012471454 type Work @default.
- W2012471454 sameAs 2012471454 @default.
- W2012471454 citedByCount "10" @default.
- W2012471454 countsByYear W20124714542013 @default.
- W2012471454 countsByYear W20124714542014 @default.
- W2012471454 countsByYear W20124714542016 @default.
- W2012471454 countsByYear W20124714542017 @default.
- W2012471454 countsByYear W20124714542021 @default.
- W2012471454 crossrefType "journal-article" @default.
- W2012471454 hasAuthorship W2012471454A5007262193 @default.
- W2012471454 hasAuthorship W2012471454A5018786888 @default.
- W2012471454 hasAuthorship W2012471454A5025381113 @default.
- W2012471454 hasAuthorship W2012471454A5036356438 @default.
- W2012471454 hasAuthorship W2012471454A5060210860 @default.
- W2012471454 hasAuthorship W2012471454A5066861312 @default.
- W2012471454 hasBestOaLocation W20124714541 @default.
- W2012471454 hasConcept C126322002 @default.
- W2012471454 hasConcept C141071460 @default.
- W2012471454 hasConcept C207103383 @default.
- W2012471454 hasConcept C2776611710 @default.
- W2012471454 hasConcept C2776694085 @default.
- W2012471454 hasConcept C2911091166 @default.
- W2012471454 hasConcept C44249647 @default.
- W2012471454 hasConcept C71924100 @default.
- W2012471454 hasConceptScore W2012471454C126322002 @default.
- W2012471454 hasConceptScore W2012471454C141071460 @default.
- W2012471454 hasConceptScore W2012471454C207103383 @default.
- W2012471454 hasConceptScore W2012471454C2776611710 @default.
- W2012471454 hasConceptScore W2012471454C2776694085 @default.
- W2012471454 hasConceptScore W2012471454C2911091166 @default.
- W2012471454 hasConceptScore W2012471454C44249647 @default.
- W2012471454 hasConceptScore W2012471454C71924100 @default.
- W2012471454 hasIssue "1" @default.
- W2012471454 hasLocation W20124714541 @default.
- W2012471454 hasLocation W20124714542 @default.
- W2012471454 hasOpenAccess W2012471454 @default.
- W2012471454 hasPrimaryLocation W20124714541 @default.
- W2012471454 hasRelatedWork W107259173 @default.
- W2012471454 hasRelatedWork W1967738824 @default.
- W2012471454 hasRelatedWork W2027570649 @default.
- W2012471454 hasRelatedWork W2062395814 @default.
- W2012471454 hasRelatedWork W2883017972 @default.
- W2012471454 hasRelatedWork W3035769840 @default.
- W2012471454 hasRelatedWork W3046070657 @default.
- W2012471454 hasRelatedWork W3088601335 @default.
- W2012471454 hasRelatedWork W3213778696 @default.
- W2012471454 hasRelatedWork W4254383208 @default.
- W2012471454 hasVolume "50" @default.
- W2012471454 isParatext "false" @default.
- W2012471454 isRetracted "false" @default.
- W2012471454 magId "2012471454" @default.
- W2012471454 workType "article" @default.